Signals are visible, but unstable.
Attention is high while evidence, use cases and enabling conditions remain uncertain.
A reading of the microbiome field.
Bridgyz currently tracks 70 microbiome trends across science, technology, markets, regulation and adoption.
The curve helps interpret where momentum is building and where apparent progress may be stalling.
Attention is high while evidence, use cases and enabling conditions remain uncertain.
Evidence, infrastructure, incentives and adoption pathways begin to converge.
The route to use, value capture and sustained demand becomes defensible.
The strategic question is not simply whether an opportunity is scientifically interesting. It is whether evidence, ecosystem conditions and adoption pathways are converging strongly enough to justify attention now. This public version makes that reasoning visible through microbiome examples; the complete working model remains part of the internal advisory toolkit.
From Bridgyz, occasionally.
Perspectives, Executive Briefings and other things worth sharing.